The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Immune-mediated dormancy: an equilibrium with cancer
Abstract
This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on the equilibrium phase, making note of previous work, suggesting that immunity might maintain cancer in a dormant state, and concluding with a description of a tractable mouse model unequivocally demonstrating that immunity can indeed hold preformed cancer in check. These findings form a framework for future studies aimed at validating immune-mediated cancer dormancy in humans with the hopes of devising new, immunotherapeutic strategies to treat established cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Self-citationThe Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Self-citationIFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Self-citationSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Models, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Self-citationDemonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Self-citationSwann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
Self-citationAdaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
Self-citationCirculating Tumor Cells in Patients with Breast Cancer Dormancy
Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1110 · Cited by 971
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Self-citationPerforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., MacGregor, D., Godfrey, D. I., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.755 · Cited by 576
Self-citationRoepman, P., Wessels, L. F. A., Kettelarij, N., Kemmeren, P., Miles, A. J., Lijnzaad, P., Tilanus, M. G. J., Koole, R., Hordijk, G.-J., van der Vliet, P. C., et al. (2005) · Nature Genetics · doi:10.1038/ng1502 · Cited by 517
Dormancy of Mammary Carcinoma After Mastectomy
Karrison, T. G., Ferguson, D. J., & Meier, P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.80 · Cited by 407
Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice
Stutman, O. (1974) · Science · doi:10.1126/science.183.4124.534 · Cited by 356
Immunodepression and Malignancy
(1976) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60179-7 · Cited by 308
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Muller, A. J., & Scherle, P. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1929 · Cited by 262
Demicheli, R., Abbattista, A., Miceli, R., Valagussa, P., & Bonadonna, G. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01807163 · Cited by 257
Transplant tumor registry: donor related malignancies
Myron Kauffman, H., McBride, M. A., Cherikh, W. S., Spain, P. C., Marks, W. H., & Roza, A. M. (2002) · Transplantation · doi:10.1097/00007890-200208150-00011 · Cited by 242
Farrar, J. D., Katz, K. H., Windsor, J., Thrush, G. R., Scheuermann, R. H., Uhr, J. W., & Street, N. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2842 · Cited by 178
Davis, T. A., Maloney, D. G., Czerwinski, D. K., Liles, T.-M., & Levy, R. (1998) · Blood · doi:10.1182/blood.v92.4.1184 · Cited by 174
Spontaneous tumor rejection by cbl-b –deficient CD8+ T cells
Loeser, S., Loser, K., Bijker, M. S., Rangachari, M., van der Burg, S. H., Wada, T., Beissert, S., Melief, C. J. M., & Penninger, J. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061699 · Cited by 161
Kauffman, H. M., McBride, M., & Delmonico, F. L. (2000) · Transplantation · doi:10.1097/00007890-200012270-00014 · Cited by 159
Farrar, J. D., Katz, K. H., Windsor, J. A., Thrush, G. R., Scheuermann, R. H., Uhr, J. W., & Street, N. E. (1999) · PubMed · Cited by 147
Wheelock, Ε. F., Weinhold, K. J., & Levich, J. D. (1981) · Advances in cancer research · doi:10.1016/s0065-230x(08)60240-7 · Cited by 138
Müller, M., Gounari, F., Prifti, S., Hacker, H. J., Schirrmacher, V., & Khazaie, K. (1998) · PubMed · Cited by 97
Maintenance of long‐term tumour‐specific T‐cell memory by residual dormant tumour cells
Mahnke, Y. D., Schwendemann, J., Beckhove, P., & Schirrmacher, V. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02163.x · Cited by 76
Tumor Dormancy and Cell Signaling. V. Regrowth of the BCL1 Tumor After Dormancy Is Established
Vitetta, E. S., Tucker, T. F., Racila, E. V., Huang, Y.-W., Marcheş, R., Lane, N., Scheuermann, R. H., Street, N. E., Watanabe, T., & Uhr, J. W. (1997) · Blood · doi:10.1182/blood.v89.12.4425 · Cited by 53
Reichard, K. K., Zhang, Q., Sanchez, L., Hozier, J. C., Viswanatha, D. S., & Foucar, K. K. (2006) · American Journal of Hematology · doi:10.1002/ajh.20389 · Cited by 42
Telomerase activity in disseminated prostate cancer cells
Pfitzenmaier, J., Ellis, W. J., Arfman, E. W., Hawley, S. J., MCLAUGHLIN, P. O., Lange, P. H., & Vessella, R. L. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06194.x · Cited by 42
Sagalowsky, A. I., & Molberg, K. H. (1999) · Urology · doi:10.1016/s0090-4295(98)00661-x · Cited by 38
Tumor Dormancy: Death and Resurrection of Cancer As Seen through Transgenic Mouse Models
Felsher, D. W. (2006) · Cell Cycle · doi:10.4161/cc.5.16.3111 · Cited by 26
Cancer Dormancy: Lessons from a B Cell Lymphoma and Adenocarcinoma of the Prostate
Rabinovsky, R., Uhr, J. W., Vitetta, E. S., & Yefenof, E. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(06)97008-0 · Cited by 22
Dudley, M. E., Sundberg, J. P., & Roopenian, D. C. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960117)65:2<204::aid-ijc13>3.0.co;2-d · Cited by 18
Relapse of Stage I Small Cell Lung Cancer Ten or More Years after the Start of Treatment
Matsui, K., Sawa, T., Suzuki, H., Nakagawa, K., Okamoto, N., Tada, T., Nagano, T., & Masuda, N. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl044 · Cited by 16
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
“However, there is also evidence that macrophage depletion has little effect on the host's susceptibility to cancer and in some cases may even be beneficial to the host (for reviews, see Ref”
BackgroundInflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Dhatchinamoorthy, K., Colbert, J. D., & Rock, K. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636568 · Cited by 1,077
Metadata
- Authors
- Teng, M. W. L., Swann, J. B., Koebel, C. M., Schreiber, R. D., & Smyth, M. J.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-30
- Volume
- 84
- Issue
- 4
- Pages
- 988-993
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2145485696
- Cited by
- 359
- References
- 36
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.